Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease
- PMID: 17430246
- DOI: 10.2174/156720507780362245
Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease
Abstract
Cerebrovascular dysfunction contributes to the cognitive decline and dementia in Alzheimer's disease (AD), and may precede cerebral amyloid angiopathy and brain accumulation of the Alzheimer's neurotoxin, amyloid beta-peptide (Abeta). The blood-brain barrier (BBB) is critical for brain Abeta homeostasis and regulates Abeta transport via two main receptors, the low density lipoprotein receptor related protein 1 (LRP1) and the receptor for advanced glycation end products (RAGE). According to the neurovascular hypothesis of AD, faulty BBB clearance of Abeta through deregulated LRP1/RAGE-mediated transport, aberrant angiogenesis and arterial dysfunction may initiate neurovascular uncoupling, Abeta accumulation, cerebrovascular regression, brain hypoperfusion and neurovascular inflammation. Ultimately these events lead to BBB compromise and chemical imbalance in the neuronal 'milieu', and result in synaptic and neuronal dysfunction. Based on the neurovascular hypothesis, we suggest an array of new potential therapeutic approaches that could be developed for AD to reduce neuroinflammation, enhance Abeta clearance and neurovascular repair, and improve cerebral blood flow. RAGE-based and LRP1-based therapeutic strategies have potential to control brain Abeta in AD, and possibly related familial cerebrovascular beta-amyloidoses. In addition, we have identified two vascularly restricted genes, GAX (growth arrest-specific homeobox), which controls LRP1 expression in brain capillaries and brain angiogenesis, and MYOCD (myocardin), which controls contractility of cerebral arterial smooth muscle cells and influences cerebral blood flow. These findings provide insights into new pathogenic pathways for the vascular dysfunction in AD and point to new therapeutic targets for AD.
Similar articles
-
New therapeutic targets in the neurovascular pathway in Alzheimer's disease.Neurotherapeutics. 2008 Jul;5(3):409-14. doi: 10.1016/j.nurt.2008.05.011. Neurotherapeutics. 2008. PMID: 18625452 Free PMC article. Review.
-
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.Acta Neuropathol. 2009 Jul;118(1):103-13. doi: 10.1007/s00401-009-0522-3. Epub 2009 Mar 25. Acta Neuropathol. 2009. PMID: 19319544 Free PMC article. Review.
-
Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.CNS Neurol Disord Drug Targets. 2009 Mar;8(1):16-30. doi: 10.2174/187152709787601867. CNS Neurol Disord Drug Targets. 2009. PMID: 19275634 Free PMC article. Review.
-
RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier.Stroke. 2004 Nov;35(11 Suppl 1):2628-31. doi: 10.1161/01.STR.0000143452.85382.d1. Epub 2004 Sep 30. Stroke. 2004. PMID: 15459432
-
Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.Cold Spring Harb Perspect Med. 2012 Oct 1;2(10):a011452. doi: 10.1101/cshperspect.a011452. Cold Spring Harb Perspect Med. 2012. PMID: 23028132 Free PMC article. Review.
Cited by 124 articles
-
Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer's Disease: the Receptor for Advanced Glycation End Products (RAGE).Front Aging Neurosci. 2020 Jul 22;12:217. doi: 10.3389/fnagi.2020.00217. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32774301 Free PMC article.
-
Protein Kinase Cɛ in the Platelet and Hippocampal Tissue as a Diagnostic Biological Marker in Alzheimer Disease.Basic Clin Neurosci. 2019 Nov-Dec;10(6):545-556. doi: 10.32598/bcn.9.10.80.1. Epub 2019 Nov 1. Basic Clin Neurosci. 2019. PMID: 32477472 Free PMC article.
-
HIV-1 and Amyloid Beta Remodel Proteome of Brain Endothelial Extracellular Vesicles.Int J Mol Sci. 2020 Apr 15;21(8):2741. doi: 10.3390/ijms21082741. Int J Mol Sci. 2020. PMID: 32326569 Free PMC article.
-
Extracellular vesicle-mediated amyloid transfer to neural progenitor cells: implications for RAGE and HIV infection.Mol Brain. 2020 Feb 17;13(1):21. doi: 10.1186/s13041-020-0562-0. Mol Brain. 2020. PMID: 32066471 Free PMC article.
-
Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina.Acta Neuropathol. 2020 May;139(5):813-836. doi: 10.1007/s00401-020-02134-w. Epub 2020 Feb 10. Acta Neuropathol. 2020. PMID: 32043162 Free PMC article.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical
-
Research Materials
-
Miscellaneous